The independent website for Australian pharmacists

News

Sigma sticking to generics

19/03/2010 | Sigma Pharmaceuticals has reaffirmed its confidence in the strength of Australia's generic drug market despite warning of a likely fall in its profitability during the past year.


Lung cancer could be next for Abraxane

19/03/2010 | The Australian sponsor of intravenous breast cancer drug Abraxane plans to apply for another indication next year after a new trial found the drug to be effective in the treatment of lung cancer as well.


Coeliac disease chronically underdiagnosed

19/03/2010 | Pharmacists can play an important role in identifying patients who may have coeliac disease, an international authority on the disease has said.


Cancer drugs predicted to boom

18/03/2010 | The market for cancer drugs has been tipped to almost double in value in the next decade amid a spate of new approvals and PBS listings in the past week.


Tamiflu resistance still a concern

18/03/2010 | The resistance to popular antiviral Tamiflu (oseltamivir) is set to be high on the agenda during the coming influenza season which is, once again, predicted to be dominated by strains of swine flu.


News archive ...

Recent newsletters

Newsletter archive

Recent comments

Most viewed articles this week

Related sites